United States · FDA National Drug Code directory
Bupropion Hydrochloride SR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-059_1b0de43f-05c2-aed6-e063-6394a90ac5df
- Product NDC
- 70436-059
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- bupropion hydrochloride
- Labeler
- Slate Run Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201102
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-01) · 70436-059-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-02) · 70436-059-02
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-05) · 70436-059-05
- 250 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-059-22) · 70436-059-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →